Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04071730 · ClinicalTrials.gov registry record · NA
Effects of Immulina on Immune Measures
A NA study, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04071730 is a NA study that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT04071730, a NA study, has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This small, randomized, double blind, placebo controlled pilot study is aimed at determining the effects of oral Immulina dietary supplementation on specific immune biomarkers in the blood.
Interventions
- DIETARY_SUPPLEMENT Immulina Dietary Supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-09-03 |
| Est. Completion | 2021-03-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04071730
The ClinicalTrials.gov registry entry for NCT04071730 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mississippi Medical Center, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Immulina Dietary Supplementation is the first listed.
NCT04071730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04071730 about?
NCT04071730 is a clinical study titled "Effects of Immulina on Immune Measures". This small, randomized, double blind, placebo controlled pilot study is aimed at determining the effects of oral Immulina dietary supplementation on specific immune biomarkers in the blood.
What is the current status of trial NCT04071730?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-09-03. Estimated completion is 2021-03-11.
What interventions are being tested in trial NCT04071730?
The interventions under investigation include: Immulina Dietary Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04071730?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.